Asbestos, ergot drugs and the pleura
Authors:
- P De VuystPVP De Vuyst
- P PfitzenmeyerPPP Pfitzenmeyer
- P CamusPCP Camus
- 1 December 1997
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 10 (12) , 2695-2698
Abstract
In this issue of the Journal, two groups of researchers with established experience in asbestos-induced respira- tory disease, independently report on patients with prior occupational exposure to asbestos, who developed exuda- tive pleural effusion and/or pleural thickening, while be- ing treated with bromocriptine for Parkinson's disease (1, 2). Ultimately, the pleural changes were largely rever- sible following drug withdrawal. Both groups prudently stressed that, since no control group was included, the interaction of, and possible potentiation between asbestos and ergot drugs currently remains speculative (1, 3). Des- pite the lack of definitive epidemiological evidence that bromocriptine and asbestos act synergistically to induce pleural thickening, fibrosis or effusion, the Editorial Board of the Journal decided to have these papers published, as a possible warning sign in occupational/iatrogenic respira- tory disease. The following pleural lesions are associated with as- bestos exposure: hyaline or calcified plaques of the pari- etal pleura; diffuse pleural thickening or fibrosis involving the visceral pleura; benign exudative or haemorrhagic effusions; and the malignant mesothelioma (4-7). The typical radiographic manifestations of asbestos-induced pleural lesions are distinctive (5, 6), but the diagnosis of early mesothelioma in patients with pleural thickening may be difficult. Classically, folding and shrinking of the lung, and rounded atelectasis (8-12) are ascribed to fibro- sis of the visceral pleura. Benign asbestos pleural effusion may be followed by pleural thickening or fibrosis, but rarely by the development of pleural mesothelioma (13).Keywords
This publication has 22 references indexed in Scilit:
- Progression of pleural and parenchymal disease on chest radiographs of workers exposed to amosite asbestos.Occupational and Environmental Medicine, 1997
- Pleural and pericardial fibrosis after ergotamine therapyRespiratory Medicine, 1994
- Pleural involvement in the carcinoid syndromeQJM: An International Journal of Medicine, 1993
- CONVENTIONAL RADIOGRAPHY IN THE DIAGNOSIS OF ASBESTOS-RELATED DISEASERadiologic Clinics of North America, 1992
- COMPUTED TOMOGRAPHY IN THE EVALUATION OF BENIGN ASBESTOS-RELATED DISORDERSRadiologic Clinics of North America, 1992
- Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis.Occupational and Environmental Medicine, 1991
- Pleuropulmonary Disease During Bromocriptine Treatment of Parkinson's DiseaseArchives of internal medicine (1960), 1988
- Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Prevalence and incidence of benign asbestos pleural effusion in a working populationJAMA, 1982
- Fibrotic Disorders Associated with Methysergide Therapy for HeadacheNew England Journal of Medicine, 1966